| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Mirae Asset Nifty 500 Healthcare ETF |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
0.00 |
| Equity |
99.94 |
| Trep |
0.06 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
35.94% |
| Top 10 Holdings |
57.91% |
| Top 25 Holdings |
84.53% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
75.1 |
| Healthcare |
24.84 |
| Cash |
0.06 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
5.12 |
| PE Ratio |
38.56 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Limited |
9.71 |
| DIVI LABORATORIES LTD |
6.86 |
| Dr Reddys Laboratories Limited |
6.70 |
| Apollo Hospitals Enterprise Limited |
6.53 |
| Max Healthcare Institute Limited |
6.14 |
| Cipla Limited |
6.12 |
| Lupin Limited |
4.65 |
| Fortis Health Care Ltd |
4.00 |
| Torrent Pharmaceuticals Limited |
3.64 |
| Laurus Labs Limited |
3.56 |
| Aurobindo Pharma Limited |
3.23 |
| Glenmark Pharmaceuticals Limited |
3.01 |
| Alkem Laboratories Limited |
2.63 |
| Biocon Limited |
2.13 |
| Mankind Pharma Limited |
2.11 |
| Zydus Lifesciences Limited |
1.86 |
| IPCA Laboratories Limited |
1.77 |
| (5) Total outstanding exposure in derivative instruments as on April 30, 2026 is Rs. Nil. |
1.48 |
| J B Chemicals and Pharma Ltd |
1.39 |
| Krishna Inst of Medical Sciences Ltd. |
1.37 |
| Sai Life Sciences Limited |
1.22 |
| Gland Pharma Limited |
1.16 |
| ACUTAAS CHEMICALS LIMITED |
1.12 |
| Abbott India Limited |
1.07 |
| Neuland Laboratories Limited |
1.07 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
